SCHEMBL24810936

SCHEMBL24810936

c1ccc(-c2cc(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)nc(-c3cc4ccccc4c4ccccc34)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 4/20 0.45
▸ KDM4E B2RXH2 4/20 0.45
▸ ATM Q13315 1/20 0.45
▸ CYP11B1 P15538 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.39
▸ HPGD P15428 5/20 0.39
▸ MAPT P10636 4/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ MEN1 O00255 6/20 0.39
▸ KMT2A Q03164 6/20 0.39
▸ NTSR1 P30989 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.36
▸ CYP1A1 P04798 1/20 0.36
▸ CYP1B1 Q16678 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ FLT3 P36888 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17943368 0.93 KDM4E (0.40) L3MBTL1KDM4EATMCYP11B1ALDH1A1
SCHEMBL17899170 0.92 KMT2A (0.43) L3MBTL1KDM4EATMCYP11B1ALDH1A1
SCHEMBL15887905 0.92 KDM4E (0.39) L3MBTL1KDM4EATMCYP11B1ALDH1A1
SCHEMBL12210999 0.92 KMT2A (0.43) L3MBTL1KDM4EATMCYP11B1ALDH1A1
SCHEMBL14416347 0.91 KMT2A (0.42) L3MBTL1KDM4EATMCYP11B1ALDH1A1
SCHEMBL17899174 0.91 KMT2A (0.42) L3MBTL1KDM4EATMCYP11B1ALDH1A1
SCHEMBL21191468 0.90 ATM (0.46) L3MBTL1KDM4EATMCYP11B1ALDH1A1
SCHEMBL17853581 0.90 DHODH (0.39) L3MBTL1KDM4EATMCYP11B1ALDH1A1
SCHEMBL17943393 0.89 ATM (0.45) L3MBTL1KDM4EATMCYP11B1ALDH1A1
SCHEMBL17853582 0.89 MAPT (0.42) L3MBTL1KDM4EATMCYP11B1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240074311-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-02-29 — — US disclosed
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 L3MBTL1 1876/4885KDM4E 3416/4885ATM 3436/4885
US-20240074311-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE RPS12, TCF12, RRP12 L3MBTL1 785/4885KDM4E 2161/4885ATM 3325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback